Rebuilding academic psychiatry in the UK: Why the Royal College of Psychiatrists’ Academic Strategy matters for the future of Psychiatry

ORCID

Abstract

Summary.The UK academic psychiatry workforce has contracted substantially over past two decades, reducing the profession’s capacity to lead innovation, train future clinicians, influence policy and translate scientific advances into clinical practice. Reference Shankar, Bowater, Laugharne, Tracy, Critchley and Young1–Reference Craddock, Antebi, Attenburrow, Bailey, Carson and Cowen3 A good example is the recent study highlighting the fact that, despite increased policy attention and funding for young people’s mental health, child and adolescent psychiatry remains markedly underrepresented academically compared with neurology despite similar specialist workforce numbers, with consequences for research, training, innovation and service development. Reference Kelleher, Poziemska, Kieseppä, Thapar, Dubicka and Lockhart4In this paper, the Royal College of Psychiatrists’ (RCPsych) Academic Psychiatry Strategy (‘strategy’) defines a coordinated national recovery plan, suggesting specific recommendations which, although possibly challenging to implement, are essential for our discipline to underpin the future of our profession.A Lancet Commission highlighted that mental disorders contribute an increasing share of the global disease burden, yet mental health research remains severely underfunded. Despite the growing impact of mental illness, investment in mental health research continues to lag far behind both the scale of the problem and funding levels for other major diseases. Reference Patel, Saxena, Lund, Thornicroft, Baingana and Bolton5Simultaneously, the UK academic psychiatry workforce has contracted substantially, with the total number of full-time-equivalent psychiatrists employed by medical schools declining by over a third over the past two decades. 6 The decline of UK academic psychiatry is especially worrying at a time when advances in neuroscience, digital health, precision medicine, artificial intelligence, genomics and real-world data science are creating major global opportunities for scientific transformation. Reference Shankar, Bowater, Laugharne, Tracy, Critchley and Young1 This decline is driven by interconnected and reinforcing barriers, including low grant application rates among academic psychiatrists, limited research training opportunities, increasing administrative burdens, National Health Service (NHS) service pressures that restrict research time and insufficient university support and resources. Together, these structural, institutional and workforce-related challenges limit the capacity of psychiatrists to actively engage in research, and risk UK psychiatry falling behind in major developments in science and technology. Reference Shankar, Bowater, Laugharne, Tracy, Critchley and Young1This Editorial examines the College academic strategy in the light of these challenges. The strategy seeks to create a sustainable framework for rebuilding academic psychiatry across the UK and is accordingly structured around seven pillars: (a) workforce and careers, (b) training and pipeline development, (c) funding and research impact, (d) regional networks, (e) diversity and mentorship, (f) innovation and translation and (g) governance and accountability. Importantly, the strategy recognises that academic psychiatry cannot remain confined to just a few tenured academics or a small number of traditional centres of institutional concentration. Instead, it proposes a broader national ecosystem of research-active services, networked collaborations and equitable academic opportunity across region, grades, gender and ethnicity.

Publication Date

2026-07-10

Publication Title

British Journal of Psychiatry

ISSN

0007-1250

Deposit Date

2026-07-12

Embargo Period

2027-01-10

Funding

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

Keywords

Evidence-based mental health, genetics, Mental health services, precision medicine, psychopharmacology

First Page

1

Last Page

4

This document is currently not available here.

This item is under embargo until 10 January 2027

Share

COinS